Involvement of IL-1beta and IL-10 in IFN-alpha-mediated antiviral gene induction in human hepatoma cells.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 12051728
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity

  2001cited by this paper
• Geranylgeranylacetone induces antiviral gene expression in human hepatoma cells.

  2001cited by this paper
• Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C.

  2000cited by this paper
• Tyk2 plays a restricted role in IFN alpha signaling, although it is required for IL-12-mediated T cell function.

  2000cited by this paper
• IL-1 beta attenuates IFN-alpha beta-induced antiviral activity and STAT1 activation in the liver: involvement of proteasome-dependent pathway.

  2000cited by this paper
• Negative regulation of cytokine signaling pathways.

  2000cited by this paper
• Chronic Hepatitis B Virus Infection: Treatment Strategies for the Next Millennium

  2000cited by this paper
• Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders.

  2000cited by this paper
• p48 (ISGF-3γ) Is Involved in Interferon-α-induced Suppression of Hepatitis B Virus Enhancer-1 Activity*

  1999cited by this paper
• The Human 2',5'-Oligoadenylate Synthetase Family: Interferon-Induced Proteins with Unique Enzymatic Properties

  1999cited by this paper
• Interleukin‐10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa

  1999cited by this paper
• Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: evidence for an IL-10-induced pathway that is independent of STAT protein activation.

  1999cited by this paper
• The Mitogen-activated Protein (MAP) Kinase p38 and Its Upstream Activator MAP Kinase Kinase 6 Are Involved in the Activation of Signal Transducer and Activator of Transcription by Hyperosmolarity*

  1999cited by this paper
• Intrahepatic expression of interleukin-1beta and tumor necrosis factor-alpha in chronic hepatitis C.

  1999cited by this paper
• Interleukin-10 inhibits expression of both interferon alpha- and interferon gamma- induced genes by suppressing tyrosine phosphorylation of STAT1.

  1999cited by this paper
• p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons

  1999cited by this paper
• Interleukin‐10 expression and function in experimental murine liver inflammation and fibrosis

  1998cited by this paper
• A Janus kinase inhibitor, JAB, is an interferon-gamma-inducible gene and confers resistance to interferons.

  1998cited by this paper
• Primary rat and mouse hepatic stellate cells express the macrophage inhibitor cytokine interleukin‐10 during the course of activation in vitro

  1998cited by this paper
• The 2–5 A system: Modulation of viral and cellular processes through acceleration of RNA degradation

  1998cited by this paper
• Interleukin‐10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice

  1998cited by this paper
• The Suppressor of Cytokine Signaling (SOCS) 1 and SOCS3 but Not SOCS2 Proteins Inhibit Interferon-mediated Antiviral and Antiproliferative Activities*

  1998cited by this paper
• Structure and function of a new STAT-induced STAT inhibitor

  1997cited by this paper
• Production of interleukins 10 and 12 by peripheral blood mononuclear cells (PBMC) in chronic hepatitis C virus (HCV) infection

  1997cited by this paper
• A family of cytokine-inducible inhibitors of signalling

  1997cited by this paper
• A new protein containing an SH2 domain that inhibits JAK kinases

  1997cited by this paper
• Essential and non‐redundant roles of p48 (ISGF3γ) and IRF‐1 in both type I and type II interferon responses, as revealed by gene targeting studies

  1996cited by this paper
• Decreased phorbol myristate acetate-induced release of tumor necrosis factor-alpha and interleukin-1 beta from peripheral blood monocytes of patients chronically infected with hepatitis C virus.

  1996cited by this paper
• IL-1 beta regulates rat mesangial cyclooxygenase II gene expression by tyrosine phosphorylation.

  1995cited by this paper
• Transcriptional responses to polypeptide ligands: the JAK-STAT pathway.

  1995cited by this paper
• A proteasome inhibitor prevents activation of NF‐kappa B and stabilizes a newly phosphorylated form of I kappa B‐alpha that is still bound to NF‐kappa B.

  1994cited by this paper
• Inactivation of a redox-sensitive protein phosphatase during the early events of tumor necrosis factor/interleukin-1 signal transduction.

  1993cited by this paper
• Interaction of interferon-alpha with interleukin-1 beta or tumor necrosis factor-alpha on hepatitis B virus enhancer activity.

  1992cited by this paper
• Spontaneous production of tumour necrosis factor alpha and interleukin-1 beta during interferon-alpha treatment of chronic HBV infection.

  1990cited by this paper
• Interrelationship of blood transfusion, non‐A, non‐B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus

  1990cited by this paper
• The hepatitis B virus

  1985cited by this paper
• Structure of two forms of the interferon‐induced (2′‐5′) oligo A synthetase of human cells based on cDNAs and gene sequences.

  1985cited by this paper

• Cytokine profiles dynamics in COVID-19 patients: a longitudinal analysis of disease severity and outcomes

  2025cites this paper
• Exploring the Impact of Different Inflammatory Cytokines on Hepatitis C Virus Infection

  2024cites this paper
• The Activated Macrophage – A Tough Fortress for Virus Invasion: How Viruses Strike Back

  2022cites this paper
• Granulocyte macrophage colony-stimulating factor has come of age: From a vaccine adjuvant to antiviral immunotherapy

  2021cites this paper
• Differential effects of orally administered Lactobacillus acidophilus L-55 on the gene expression of cytokines and master immune switches in the ileum and spleen of laying hen with an attenuated Newcastle disease virus vaccine

  2021cites this paper
• Identification of Interleukin1β as an Amplifier of Interferon alpha-induced Antiviral Responses

  2020cites this paper
• IL-36 family cytokines in protective versus destructive inflammation.

  2020cites this paper
• IL-1β enhances anti-viral effect of IFN-α on HCV replication by negatively modulating ERK2 activation.

  2020cites this paper
• Inflammasome Genes' Polymorphisms in Egyptian Chronic Hepatitis C Patients: Influence on Vulnerability to Infection and Response to Treatment

  2019cites this paper
• Interleukin-1β Signaling in Dendritic Cells Induces Antiviral Interferon Responses

  2018cites this paper
• IL-1α correlates with severity of hepatitis C virus-related liver diseases

  2018cites this paper
• Model Based Targeting of IL-6-Induced Inflammatory Responses in Cultured Primary Hepatocytes to Improve Application of the JAK Inhibitor Ruxolitinib

  2017cites this paper
• Upregulation of ICAM-1 and IL-1β protein expression promotes lung injury in chronic obstructive pulmonary disease.

  2016cites this paper
• Simian varicella virus and varicella-zoster virus immune evasion of NFkB activation

  2015cites this paper
• Expression and mechanism of action of the SARI tumor suppressor in prostate cancer.

  2015cites this paper
• West Nile virus infection and immunity

  2013cites this paper
• Relation of interleukin-1β gene to treatment response in chronic patients infected with HCV genotype 4.

  2013cites this paper
• Interferon Gamma/IL10 Ratio Production in Response to Host Antigens may Predict Acute Graft Versus Host Disease after Allogeneic Stem Cell Transplantation from a Sibling

  2013cites this paper
• IL-1β Signaling Promotes CNS-Intrinsic Immune Control of West Nile Virus Infection

  2012cites this paper
• The Role of Protein Kinase R in the Interferon Response

  2011cites this paper
• IL-29 and IFN-α regulate the expression of MxA, 2′,5′-OAS and PKR genes in association with the activation of Raf-MEK-ERK and PI3K-AKT signal pathways in HepG2.2.15 cells

  2010cites this paper
• Epstein-Barr Virus Interferes with the Amplification of IFNα Secretion by Activating Suppressor of Cytokine Signaling 3 in Primary Human Monocytes

  2010cites this paper
• Hepatitis C virus kinetics during the first phase of pegylated interferon‐α‐2b with ribavirin therapy in patients with living donor liver transplantation

  2009cites this paper
• Up-Regulation of Hepatitis C Virus Replication and Production by Inhibition of MEK/ERK Signaling

  2009cites this paper
• Interferon-α-induced mTOR activation is an anti-hepatitis C virus signal via the phosphatidylinositol 3-kinase-Akt-independent pathway

  2009cites this paper
• Differential effects of calcineurin inhibitors, tacrolimus and cyclosporin a, on interferon‐induced antiviral protein in human hepatocyte cells

  2008cites this paper
• Toll-like receptor (TLR)2 and TLR3 synergy and cross-inhibition in murine myeloid dendritic cells.

  2008cites this paper
• Expression of biomarkers of interferon type I in patients suffering from chronic diseases

  2007cites this paper
• Antiviral and immunoregulatory activities of IFN-gamma depend on constitutively expressed IL-1alpha.

  2007cites this paper
• Sustained virological response to interferon‐α is associated with improved outcome in HCV‐related cirrhosis: A retrospective study

  2007cites this paper
• A BRIEF COMMUNICATION

  2007influential citation
• Autoregulatory Role of Interleukin-10 in Hepatitis C Patients Treated with IFN-α

  2004cites this paper
• Interleukin-10 Therapy—Review of a New Approach

  2003cites this paper
• Interleukin-1 Inhibits Hepatitis C Virus Subgenomic RNA Replication by Activation of Extracellular Regulated Kinase Pathway

  2003cites this paper
• Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line

  2003cites this paper